Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1952 Jul 1;96(1):71–82. doi: 10.1084/jem.96.1.71

PREPARATION AND PROPERTIES OF TYPE-SPECIFIC M ANTIGEN ISOLATED FROM A GROUP A, TYPE 1 HEMOLYTIC STREPTOCOCCUS

Rebecca C Lancefield 1, Gertrude E Perlmann 1
PMCID: PMC2136131  PMID: 14946330

Abstract

Type-specific M antigen was extracted by heating type 1 group A streptococci at pH 2 in a boiling water bath. The protein was then purified by digestion with a preparation of crystalline ribonuclease which was free of proteolytic activity. It was further purified by fractional precipitation with (NH4)2SO4. Elementary chemical analysis of the preparation thus obtained showed an absence of phosphorus and a sulfur content of 2.46 per cent. In the ultraviolet the maximum absorption was at a wave length of 276 mµ and the minimum at 255 mµ. In electrophoresis experiments the preparation showed a single peak in the pH range of 3 to 9, but considerable boundary spreading was observed. The type 1 M antigen was isoelectric at pH 5.3 in sodium acetate buffer of ionic strength 0.1. The serological reactivity of the protein isolated was typical of type 1 M antigen. This protein induced the formation in rabbits of type-specific precipitins and protective antibodies. The absorption of type 1 antibacterial serum with the purified M antigen removed both the protective antibodies and the type-specific precipitins from the serum.

Full Text

The Full Text of this article is available as a PDF (572.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Elliott S. D. A PROTEOLYTIC ENZYME PRODUCED BY GROUP A STREPTOCOCCI WITH SPECIAL REFERENCE TO ITS EFFECT ON THE TYPE-SPECIFIC M ANTIGEN. J Exp Med. 1945 Jun 1;81(6):573–592. doi: 10.1084/jem.81.6.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hirst G. K., Lancefield R. C. ANTIGENIC PROPERTIES OF THE TYPE-SPECIFIC SUBSTANCE DERIVED FROM GROUP A HEMOLYTIC STREPTOCOCCI. J Exp Med. 1939 Feb 28;69(3):425–445. doi: 10.1084/jem.69.3.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kuttner A. G., Lenert T. F. THE OCCURRENCE OF BACTERIOSTATIC PROPERTIES IN THE BLOOD OF PATIENTS AFTER RECOVERY FROM STREPTOCOCCAL PHARYNGITIS. J Clin Invest. 1944 Mar;23(2):151–161. doi: 10.1172/JCI101478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lancefield R. C., Dole V. P. THE PROPERTIES OF T ANTIGENS EXTRACTED FROM GROUP A HEMOLYTIC STREPTOCOCCI. J Exp Med. 1946 Oct 31;84(5):449–471. doi: 10.1084/jem.84.5.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lancefield R. C. THE SIGNIFICANCE OF M AND T ANTIGENS IN THE CROSS REACTIONS BETWEEN CERTAIN TYPES OF GROUP A HEMOLYTIC STREPTOCOCCI. J Exp Med. 1940 Mar 31;71(4):539–550. doi: 10.1084/jem.71.4.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lancefield R. C. TYPE-SPECIFIC ANTIGENS, M AND T, OF MATT AND GLOSSY VARIANTS OF GROUP A HEMOLYTIC STREPTOCOCCI. J Exp Med. 1940 Mar 31;71(4):521–537. doi: 10.1084/jem.71.4.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lancefield R. C., Todd E. W. ANTIGENIC DIFFERENCES BETWEEN MATT HEMOLYTIC STREPTOCOCCI AND THEIR GLOSSY VARIANTS. J Exp Med. 1928 Nov 30;48(6):769–790. doi: 10.1084/jem.48.6.769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. ROTHBARD S. Protective effect of hyaluronidase and type-specific anti-M serum on experimental group A streptococcus infection in mice. J Exp Med. 1948 Sep 1;88(3):325–342. doi: 10.1084/jem.88.3.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. ROTHBARD S., WATSON R. F. Bacteriologic and immunologic studies on patients with hemolytic streptococcic infections as related to rheumatic fever. Arch Intern Med (Chic) 1948 Sep;82(3):229–250. doi: 10.1001/archinte.1948.00220270014002. [DOI] [PubMed] [Google Scholar]
  10. ROTHBARD S., WATSON R. F. Variation occurring in group A streptococci during human infection; progressive loss of M substance correlated with increasing susceptibility to bacteriostasis. J Exp Med. 1948 Jun 1;87(6):521–533. doi: 10.1084/jem.87.6.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Swift H. F., Wilson A. T., Lancefield R. C. TYPING GROUP A HEMOLYTIC STREPTOCOCCI BY M PRECIPITIN REACTIONS IN CAPILLARY PIPETTES. J Exp Med. 1943 Aug 1;78(2):127–133. doi: 10.1084/jem.78.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Todd E. W., Lancefield R. C. VARIANTS OF HEMOLYTIC STREPTOCOCCI; THEIR RELATION TO TYPE-SPECIFIC SUBSTANCE, VIRULENCE, AND TOXIN. J Exp Med. 1928 Nov 30;48(6):751–767. doi: 10.1084/jem.48.6.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Watson R. F., Lancefield R. C. STUDIES ON THE ANTIGENIC COMPOSITION OF GROUP A HEMOLYTIC STREPTOCOCCI : III. TYPES WITH SEROLOGICALLY IDENTICAL M BUT DISTINCT T ANTIGENS: TYPES 10 AND 12. J Exp Med. 1944 Jan 1;79(1):89–98. doi: 10.1084/jem.79.1.89. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES